Видео с ютуба Gsk3

Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight

GSK-3 Inhibitors - Treatment of Diabetes and CNS Disorders: Targeting the Substrate Binding Site

Elraglusib, a novel small molecule inhibitor of GSK-3

Lithium's Hypothetical Mechanism of Action

Glycogen Synthase Regulation

Novel GSK-3 Inhibitors for Treating CNS Disorders

The path from insulin to GSK3 and glycogen synthase

The anti-lymphoma effects of the GSK3 inhibitor elraglusib are not attributable to GSK3

Glycogen synthase kinase

Priming of GSK3 phosphorylation of glycogen synthase

JCB : GSK3- and PRMT-1-dependent modifications of desmoplakin control desmoplakin-cytoskeleton...

A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle...

gsk3

GSK-3b in Neurodegeneration: Cell signalling

GSK3

The GSK3 from Moniliophthora roreri: Repurposing... - Décio Lisboa - 3DSIG - Poster - ISMB 2022

Die dunkle Wahrheit der Pharmaindustrie – Lithium und GSK3!

Is Lithium Still Worth It? Here’s the Truth

Targeting networks and AKT/GSK3 signalling in the actions of mood stabilizers... (TR)

Unlocking Lithium's Secrets for Brain Health

SMAD2, GSK3 and IGF1R

Niewielka dawka — potężna ochrona przed chorobą Alzheimera

Axonal Autophagy Regulated by GSK3b Phosphorylation of MCL1